Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

78.80USD
3 May 2016
Change (% chg)

$-0.60 (-0.76%)
Prev Close
$79.40
Open
$79.30
Day's High
$79.52
Day's Low
$76.55
Volume
128,456
Avg. Vol
121,107
52-wk High
$82.36
52-wk Low
$60.02

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $3,711.58
Shares Outstanding(Mil.): 47.10
Dividend: --
Yield (%): --

Financials

Search Stocks

BRIEF-Charles River has committed to invest up to $10 mln in Biomotiv

April 13 Charles River Laboratories International Inc

14 Apr 2016

Charles River Labs to buy research firm for about $585 million

Charles River Laboratories International Inc said it would buy privately held WIL Research for about $585 million in cash to enhance its contract research business and expand in continental Europe.

07 Jan 2016

UPDATE 2-Charles River Labs to buy research firm for about $585 mln

* To improve pricing in preclinical testing - analyst (Adds analyst comment, updates share movement)

07 Jan 2016

Charles River Labs to buy research firm for about $585 mln

Jan 7 Charles River Laboratories International Inc said it would buy privately held WIL Research for about $585 million in cash to enhance its contract research business and expand its geographic footprint.

07 Jan 2016

Earnings vs. Estimates

Search Stocks